Celldex Therapeutics
CLDX
#4691
Rank
S$2.54 B
Marketcap
S$38.35
Share price
6.44%
Change (1 day)
7.39%
Change (1 year)

Celldex Therapeutics (CLDX) - Total debt

Total debt on the balance sheet as of September 2025 : S$3.39 Million

According to Celldex Therapeutics's latest financial reports the company's total debt is S$3.39 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Celldex Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$5.18 M54.38%
2023-12-31S$3.35 M-37.91%
2022-12-31S$5.4 M31.47%
2021-12-31S$4.11 M-10.7%
2020-12-31S$4.6 M-6.59%
2019-12-31S$4.93 M
2018-12-31N/A-100%
2017-12-31S$8.78 M
2015-12-31S$6.24 M82.47%
2014-12-31S$3.42 M
2013-12-31N/A-100%
2012-12-31S$13.86 M-29.3%
2011-12-31S$19.61 M40.74%
2010-12-31S$13.93 M-28.28%
2009-12-31S$19.42 M6132.31%
2008-12-31S$0.31 M-95.81%
2007-12-31S$7.43 M4.46%
2006-12-31S$7.11 M104.83%
2005-12-31S$3.47 M1042.31%
2004-12-31S$0.3 M
2000-12-31S$0.47 M-49.24%
1999-12-31S$0.93 M-64.52%
1998-12-31S$2.64 M-2.08%
1997-12-31S$2.69 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Seagen
SGEN
S$0.14 B 4,229.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$59.3 M 1,646.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.85 B 25,199.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$70.72 B 2,082,578.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$78.84 B 2,321,456.66%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$30.91 B 910,315.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA